article · Clinical Infectious Diseases

High Prevalence of Anti–Severe Acute Respiratory Syndrome Coronavirus 2 (Anti–SARS-CoV-2) Antibodies After the First Wave of Coronavirus Disease 2019 (COVID-19) in Kinshasa, Democratic Republic of the Congo: Results of a Cross-sectional Household-Based Survey

Antoine Nkuba-Ndaye
Jean-François Étard
Trésor M Kabeya
Emilande Guichet
Naomi M Mitongo
Yannick Munyeku-Bazitama
Guillaume Thaurignac
Fabian H. Leendertz
Marc K Yambayamba
Paul M Tshiminyi
Lionel K Baketana
Placide Mbala
Raphaël Pelloquin
Sheila Makiala‐Mandanda
Élysée Matungulu
Veerle Vanlerberghe
Benito M. Kazenza
Éric Delaporte
David Maman
Martine Peeters
Jean-Jacques Muyembe
Ahidjo Ayouba
Steve Ahuka

202152 citationsOpen accessUniversité de Kinshasa (UNIKIN)

In plain language

The abstract on record is too brief for a reliable plain-language summary, so none has been generated.

Abstract

The prevalence of SARS-CoV-2 is much higher than the number of COVID-19 cases reported. These results justify the organization of a sequential series of serosurveys by public health authorities to adapt response measures to the dynamics of the pandemic.

Research topics

SARS-CoV-2 and COVID-19 Research
COVID-19 epidemiological studies
COVID-19 Clinical Research Studies

Sustainable Development Goals

3Good Health and Well-being

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1093/cid/ciab515

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.